Difficulty: Medium
Average Score: 77%
Practice
Alpha methyldopa
Correct answer
C
Rationale
Rationale:
Alpha methyldopa is a centrally acting alpha-2 adrenergic agonist primarily used as an antihypertensive agent. The correct answer is C) Is valuable in patients with compromised renal function. This is because alpha methyldopa is unique in that it does not require dose adjustment in patients with renal impairment, making it a suitable choice for individuals with compromised renal function as it is mainly metabolized in the liver.
Option A) Is ineffective when given orally is incorrect because alpha methyldopa is actually effective when administered orally. It is well absorbed from the gastrointestinal tract and undergoes hepatic metabolism to its active form.
Option B) Decreases serum prolactin levels is incorrect because alpha methyldopa is not known to have a significant effect on prolactin levels. It primarily acts by stimulating alpha-2 adrenergic receptors in the CNS leading to decreased sympathetic outflow and subsequent reduction in blood pressure.
Option D) Causes troublesome postural hypotension is incorrect because while alpha methyldopa can cause orthostatic hypotension, it is not typically considered troublesome compared to other antihypertensive agents like alpha-1 blockers or diuretics.
Educational Context:
Understanding the pharmacology of CNS drugs, such as alpha methyldopa, is crucial for healthcare professionals, especially pharmacists, physicians, and nurses. Knowing the unique characteristics of each drug helps in making informed decisions regarding drug selection, dosing, and monitoring, particularly in patients with specific comorbidities like compromised renal function. This knowledge ensures safe and effective pharmacotherapy, optimizing patient outcomes.
Alpha methyldopa is a centrally acting alpha-2 adrenergic agonist primarily used as an antihypertensive agent. The correct answer is C) Is valuable in patients with compromised renal function. This is because alpha methyldopa is unique in that it does not require dose adjustment in patients with renal impairment, making it a suitable choice for individuals with compromised renal function as it is mainly metabolized in the liver.
Option A) Is ineffective when given orally is incorrect because alpha methyldopa is actually effective when administered orally. It is well absorbed from the gastrointestinal tract and undergoes hepatic metabolism to its active form.
Option B) Decreases serum prolactin levels is incorrect because alpha methyldopa is not known to have a significant effect on prolactin levels. It primarily acts by stimulating alpha-2 adrenergic receptors in the CNS leading to decreased sympathetic outflow and subsequent reduction in blood pressure.
Option D) Causes troublesome postural hypotension is incorrect because while alpha methyldopa can cause orthostatic hypotension, it is not typically considered troublesome compared to other antihypertensive agents like alpha-1 blockers or diuretics.
Educational Context:
Understanding the pharmacology of CNS drugs, such as alpha methyldopa, is crucial for healthcare professionals, especially pharmacists, physicians, and nurses. Knowing the unique characteristics of each drug helps in making informed decisions regarding drug selection, dosing, and monitoring, particularly in patients with specific comorbidities like compromised renal function. This knowledge ensures safe and effective pharmacotherapy, optimizing patient outcomes.